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Abstract In the present study, we examined the effect of atrial 
natriuretic peptide (ANP) on Ca2+ efflux from freshly isolated 
adult rat cardiomyocytes. Rat ANP(l-28) stimulated the efflux 
of 45Ca2+ from the cells in a concentration-dependent manner 
(10 8 M to 10 6 M). The 45Ca2+ efflux was not affected by 
removal of extracellular Ca2+, but was dependent on the presence 
of extracellular Na+. In addition, rat ANP(l-28) caused 22Na+ 
influx into the cells. The 45Ca2+ efflux was also stimulated by C-
type natriuretic peptide-22 (CNP-22), but not by rat brain 
natriuretic peptide-45 (BNP-45). It was also observed that both 
rat ANP(l-28) and CNP-22 stimulated guanosine 3',5'-cyclic 
monophosphate production within the cells. These results indicate 
that ANP stimulates Na+-dependent 45Ca2+ efflux from freshly 
isolated adult rat cardiomyocytes, probably through Na+/Ca2+ 
exchange, and that the stimulatory effect of ANP on Ca2+ efflux 
may be mediated via the natriuretic peptide receptor which has 
been shown to couple to guanylate cyclase. Since it is reported 
that Na+/Ca2+ exchange is important in calcium homeostasis 
within cells, ANP may play a role in the extrusion of 
intracellular Ca2+ from isolated adult rat cardiomyocytes. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Atrial natriuretic peptide (ANP) was originally identified as 
a natriuretic substance from human atrium [1]. It has also 
been reported that this peptide affects water balance [2] and 
vascular tone [3] in many species. In cardiac tissues, ANP has 
been shown to cause a negative inotropic effect [4] and cell 
proliferation [5] in an autocrine/paracrine manner. The nega-
tive inotropic effect of ANP on the heart has been implicated 
to the inhibition of voltage-dependent Ca2+ channels in the 
cardiac cell membrane [6]. On the other hand, it has been 
reported that ANP reduces basal cytosolic free Ca2+ concen-
tration ([Ca2+]i) without affecting voltage-gated Ca2+ currents 
in guinea-pig cardiomyocytes [7]. Therefore, the effect of ANP 
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on intracellular Ca2+ homeostasis in cardiomyocytes is cur-
rently a topic of controversy. The exact mechanism of ANP 
on [Ca2+]¡ regulation in cardiomyocytes still remains to be 
elucidated. 
It is well known that several physiological stimuli cause a 
transient rise in [Ca2+]¡ [8,9] which leads to contraction of 
cardiomyocytes. Following stimulation, increased [Ca2+]; 
must rapidly return to resting level in order to elicit a response 
to subsequent stimulation. This decrease in [Ca2+]¡ may be 
attributed mainly to the mechanism of Na+/Ca2+ exchange 
at the plasma membrane and Ca2+ uptake into the sarcoplas-
mic reticulum [10]. However, little is known about the precise 
mechanism of this decrease. We have thus hypothesized that 
ANP is involved in the reduction of [Ca2+]¡ in cardiomyo-
cytes. In the present study, we focused on the mechanism of 
the decrease in [Ca2+]¡ and examined the effect of rat ANP(1-
28) itself on Ca2+ efflux from freshly isolated, quiescent adult 
rat cardiomyocytes. Moreover, the effect of rat ANP(l-28) on 
Ca2+ efflux was compared to that of rat brain natriuretic 
peptide-45 (BNP-45) and C-type natriuretic peptide-22 
(CNP-22). 
2. Materials and methods 
2.1. Preparation of adult rat cardiomyocytes 
Treatment of animals was based on the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes of 
Health (NIH publication No. 85-23, revised in 1985). Isolation of 
adult rat cardiomyocytes was performed by the method of Mitra 
and Morad with minor modifications [11]. Male Sprague-Dawley 
rats weighing 250-300 g were used. The rats were anesthetized by 
inhalation of saturated diethylether gas and were administered hepa-
rin (1000 U/kg) intravenously. The heart was excised and the aorta 
cannulated in a Langendorff perfusión apparatus[12]. The heart was 
then perfused for 3 min with calcium-free buffer medium (medium A: 
135 mM NaCl, 5.6 mM KC1, 1.0 mM MgCl2, 0.33 mM NaH2P04, 
10.0 mM HEPES, 0.2% bovine serum albumin (BSA), adjusted with 
NaOH to pH 7.30). Thereafter, the perfusión medium was changed to 
a cell dispersing medium, medium B (medium A supplemented with 
0.2% collagenase I and 0.04% protease XIV) for 12 min. After diges-
tion, these enzymes were washed out with medium C (medium A 
containing 220 |iM of CaCl2) for 3 min. After the completion of 
perfusión, the heart was removed from the cannula and placed in a 
Petri dish containing 25 ml of medium D (medium C supplemented 
with 2% BSA). Small pieces of tissue (3X3 mm) were cut from the 
ventricle and gently shaken in 25 ml of medium D to release the 
dispersed cells. The cells were resuspended once in 25 ml of a calci-
um-containing medium to prevent Ca2+ paradox [13] (0.44 mM of 
CaCl2 with medium D, to increase Ca2+ concentration stepwise) 
and centrifuged at 15 Xg for 30 s. Afterwards, the cells were washed 
once with modified Krebs-Henseleit bicarbonate buffer solution (K-H 
solution) (135 mM NaCl, 5.6 mM KC1, 1.2 mM MgS04, 1.2 mM 
KH2P04, 25 mM NaHC03, 2.2 mM CaCl2, 10 mM glucose, adjusted 
with HC1 to pH 7.40) oxygenated with 95% of 02 and 5% of C02 gas 
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mixture. Finally, the isolated cardiomyocytes were resuspended in 5 ml 
of K-H solution. The counted number of intact, rod-shaped cells 
using a hemocytometer was approximately 1.0 XlO6 cells/ml, and 
these cells were quiescent when observed by microscope. 
2.2. 45Ca2+ efflux assay 
The method for measurement of 45Ca2+ efflux from the cells was as 
described previously [14]. Briefly, the isolated adult rat cardiomyo-
cytes were incubated with 5 ml of K-H solution containing 45CaCl2 
(4 uCi/ml) for one hour at 37°C. Then 1.5-ml volumes of the cell 
suspension (ca. 1.5 X 106 cells) were resuspended and centrifuged twice 
with 10 ml of K-H solution and were applied to a custom-made 
superfusion column consisting of 20 urn pore-size filter. This column 
was cone-shaped, 5 cm long and 1 cm in diameter, and the cells were 
stratified on the filter. K-H solution was dropped onto the cells to 
keep the medium volume constant (ca. 1 ml), and the effluent from the 
column was collected. The cells were then superfused with K-H sol-
ution for 15 min to remove the unincorporated 45Ca2+ (flow rate of 
approximately 1 ml/min). Afterwards, the effluent was collected 15 
times at intervals of 30 s (ca. 1 ml/min) to determine the basal efflux 
level. The cells were then superfused with the reaction mixture with or 
without test agents, and the effluent was again collected 15 X at in-
tervals of 30 s to determine the agonist-stimulated 45Ca2+ efflux levels. 
After agonist stimulation, the cells in the column were collected and 
dissolved in 1 ml of 1% Triton X-100 solution to determine the re-
sidual 45Ca2+ in the cells. For experiments with Ca2+ or Na+ removed 
from the medium, Ca2+-free K-H solution or Na+-deficient medium 
which was prepared with sucrose instead of Na+ was used. Extracel-
lular rat ANP(l-28) administered at 10~6 M did not cause contrac-
tion of the cardiomyocytes, as confirmed by microscopic observation. 
Samples were counted in 10 ml of liquid scintillation fluid for a 2-min 
period. The total radioactivity of 45Ca2+ in the cells was determined 
as the sum of the radioactivity in each fraction and the residual radio-
activity, and this value was used to calculate the fractional release of 
Ca2+ from the cells in each period. 
2.3. Measurement of22Na+ influx into the cells 
The isolated adult rat cardiomyocytes were incubated with 1 ml of 
K-H solution containing 22Na+ (3 uCi/ml) in the presence or absence 
of test agents for 5 min at 37°C. After incubation, the medium was 
discarded and the cells were washed 3 X with 1 ml of ice-cold K-H 
solution. The intracellular 22Na+ was then extracted with 1 ml of 1% 
Triton X-100 and measured with a gamma counter as described pre-
viously [15]. 
2.4. Measurement of guanosine 3',5'-cyclic monophosphate (cGMP) 
production within the cells 
Rat ANP(l-28)-induced guanosine 3',5'-cyclic monophosphate 
(cGMP) production was measured using a commercially available 
enzyme immunoassay kit [16]. Briefly, 1 ml of cell suspension 
(1 X106 cells) was preincubated at 37°C for 20 min with 5X 10~4 M 
3-isobutyl-l-methylxantine (IBMX) to facilitate the measurement of 
cGMP production. Then, the cells were incubated at 37°C for 10 min 
with or without test agents, and the reaction was stopped by the 
addition of 100 ml of 100% trichloroacetic acid. To sediment the 
precipitate, the test tube was centrifuged at 2000 Xg for 10 min and 
the resultant cGMP in the supernatant was assayed with the cyclic 
GMP enzyme immunoassay system. Results were expressed as pmol/ 
106 cells. 
2.5. Statistics 
One-way ANOVA was used to determine the significance among 
groups, after which modified i-test with Bonferroni correction was 
used for comparison between individual groups. A value of P < 0.05 
was considered to be statistically significant. 
2.6. Chemicals 
45CaCi2 and the cyclic GMP enzyme immunoassay system were 
obtained from Amersham Corp. (Tokyo, Japan). Rat ANP(l-28), 
rat BNP-45 and CNP-22 were purchased from Peptide Institute Inc. 
(Osaka, Japan). Sodium nitroprusside was obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). All other chemicals used were 
commercial products of reagent grade. 
3. Results 
3.1. Effect of ANP on 45Ca2+ efflux from freshly isolated adult 
rat cardiomyocytes 
The stimulatory effect of rat A N P ( l - 2 8 ) on 4 5 Ca 2 + efflux 
was dose-dependent at concentrations of 10~8 to 10~6 M (Fig. 
1). The efflux of 4 5 Ca 2 + increased to a peak value within 
approximately 1 min after A N P addition. The peak value 
with 10"6 M rat A N P ( l - 2 8 ) was 2.1 ± 0 . 1 7 % of total 4 5Ca2+ 
within the cells. After the peak, the efflux level decreased 
rapidly within the next 5 min. The efflux then returned to 
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Fig. 1. Effects of various concentrations of rat ANP(l-28) on 
45Ca2+ efflux from freshly isolated adult rat cardiomyocytes. Data 
are means for 5 separate experiments. The maximal standard error 
was 8.1% of the mean value on ordinate at peak. To avoid compli-
cating the figure, error bars are omitted. All peak levels with rat 
ANP(l-28) at 10~8 M to 10~6 M were significantly greater than the 
control level (*P< 0.05). 
3.2. Influence of removal of extracellular Ca2+ or Na+ on 
ANP-stimulated ^Ca2* efflux 
Next, we determined whether ANP-induced 4 5 Ca 2 + efflux is 
dependent on the presence of extracellular Ca 2 + or N a + . We 
carried out a series of experiments in the absence of extrac-
ellular Ca 2 + or Na+. As shown in Fig. 2, rat A N P ( l - 2 8 ) -
induced 4 5 Ca 2 + efflux was not influenced by the absence of 
extracellular C a 2 + . However, Na+-free medium which was 
completely replaced by sucrose significantly inhibited rat 
ANP(l-28)- induced 4 5 Ca 2 + efflux from the cells. F rom these 
results, it is assumed that the effect of A N P in stimulating 
C a 2 + efflux across the plasma membrane may be mediated 
by an extracellular Na + -dependent mechanism in isolated 
rat cardiomyocytes, presumably N a + / C a 2 + exchange mecha-
3.3. Effect of ANP on 22Na+ influx into the cells 
To evaluate the possibility that ANP-induced 4 5 Ca 2 + efflux 
from the cells is mediated by the N a + / C a 2 + exchange mecha-
nism, we examined the effect of rat A N P ( l - 2 8 ) on 2 2 N a + 
influx into the cardiomyocytes. Experiments were performed 
using normal medium and Ca2 +-free medium. 2 2 Na+ influx 
into the cells was induced by A N P (control, 20.2 ± 1.7 nmol/ 
106 cells; 1 0 - 6 M rat A N P ( l - 2 8 ) , 32.1 ±2 .8 nmol/106 cells; 
10"6 M rat A N P ( l - 2 8 ) in Ca 2 + medium, 29.5 ±2 .1 nmol/106 
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Fig. 2. Influence of Ca2+ or Na+ removal from the medium on rat 
ANP(l-28)-induced 45Ca2+ efflux from freshly isolated adult rat car-
diomyocytes. The medium was changed to Ca2+- or Na+-free me-
dium 5 min prior to rat ANP(l-28) administration. Na+-free me-
dium was prepared using sucrose instead of Na+. Data are means 
for 5 separate experiments. The maximal standard error was 9.5% 
of the mean value on ordinate at peak. To avoid complicating the 
figure, error bars are omitted. The peak level with rat ANP(l-28) in 
Na+-deflcient medium was significantly less than that with rat 
ANP(l-28) in normal medium (*P<0.05). 
cells). Therefore, ANP-induced 45Ca2+ efflux from the cells, 
which is mediated by the Na+/Ca2+ exchange mechanism, is 
suggested. 
3.4. Effects of rat BNP-45 and CNP-22 on 45Ca2+ efflux from 
the cells and comparison with that of rat ANP(l-28) 
To determine whether ANP specifically stimulates 45Ca2+ 
efflux from the cells, we examined the effects of other types 
of natriuretic peptides on 45Ca2+ efflux. As shown in Table 1, 
the efflux of 45Ca2+ from the cells was stimulated by CNP-22 
(10~6 M) to almost the same extent as by rat ANP(l-28) 
(10~6 M). However, rat BNP-45 (10~6 M) failed to cause 
45Ca2+ efflux from the cardiomyocytes. 
3.5. Effects of rat ANP(l-28), rat BNP-45 and CNP-22 on 
cGMP production in isolated adult rat cardiomyocytes and 
comparison with that of sodium nitroprusside 
As shown in Table 2, application of 10~6 M rat ANP(l-28) 
caused a significant increase in cGMP production during the 
10 min incubation. The rat BNP-45 (10 -6 M)-induced cGMP 
Table 1 
Effects of rat ANP(l-28), rat BNP-45 and CNP-22 on 45Ca2+ efflux 
from freshly isolated adult rat cardiomyocytes 
Peak of 45Ca2+ efflux (% of cell content) 
Control 0.41 ± 0.06 
Rat ANP(l-28) (lO^6 M) 2.1 ± 0.17* 
Rat BNP-45 (10"6 M) 0.62 ±0.08 
CNP-22 (10"6 M) 2.0±0.18* 
Cells were preloaded with 45CaCl2 as described in the text. After the 
stabilization of basal efflux level, rat ANP(l-28) or rat BNP-45 or 
CNP-22 was added at the final concentration of 10~6 M, then the cells 
were superfused for 7.5 min. Data are means ± S.E. for 5 separate 
experiments. The asterisk (*) represents the statistical significance 
from the control value (P < 0.05). 
Table 2 
Effects of rat ANP(l-28), rat BNP-45 and CNP-22 on cGMP pro-
duction in isolated adult rat cardiomyocytes 
pmol/106 cells 
Control 
Rat ANP(l-28) (10~6 M) 
Rat BNP-45 (10"6 M) 
CNP-22 (10 -6 M) 






Cells were preincubated with IBMX (5X10 4 M) as described in the 
text. Then, rat ANP(l-28) or rat BNP-45 or CNP-22 was added at the 
final concentration of 10~6 M and incubated for 10 min. Data are 
means ± S.E. for 3 separate experiments. The asterisk (*) represents 
the statistical significance from the control value (P < 0.05). 
production was less pronounced than that of ANP and there 
was no statistical significance from the control value. CNP-22 
(10~6 M) also caused a significant rise in cGMP accumulation 
to almost the same extent as ANP. Sodium nitroprusside 
(10~4 M), which is known to be a potent stimulator of gua-
nylate cyclase, caused approximately a 10-fold increase in 
cGMP production over the basal value. 
4. Discussion 
The effect of ANP on [Ca2+]¡ homeostasis in cardiomyo-
cytes is a controversial issue. It has been reported that ANP 
decreases isoprenaline-induced Ca2+ channel current without 
affecting basal Ca2+ channel current [17]. On the other hand, 
one study has shown a reduction of basal [Ca2+]¡ caused by 
ANP in guinea pig cardiomyocytes [7]. It has also been re-
ported that ANP reduces basal [Ca2+]¡ through the activation 
of a cGMP-mediated process in cardiac myocytes [18]. How-
ever, no investigation has directly measured the ANP-induced 
Ca2+ efflux from cardiomyocytes. We have hypothesized that 
ANP may cause Ca2+ efflux from the cells. In the present 
study, we thus examined the mechanism by which rat 
ANP(l-28) stimulates Ca2+ efflux from adult rat cardiomyo-
cytes preloaded with 45CaCl2. 
Results shown in Fig. 1 revealed that rat ANP(l-28) caused 
a significant Ca2+ efflux from cardiomyocytes in a concentra-
tion-dependent manner (10~8 M to 10~6 M). The efflux of 
45Ca2+ increased to a peak value within approximately 
1 min after ANP addition, and decreased rapidly within the 
next 5 min. This ability of ANP to mobilize Ca2+ outside the 
plasma membrane has not been previously identified, since 
earlier reports have concentrated on [Ca2+]¡ measurement 
[7,18]. Our method of superfusion detected, for the first time 
to our knowledge, an ANP-induced Ca2+ efflux from cardio-
myocytes preloaded with 45CaCl2. 
To investigate the intracellular mechanism of ANP-induced 
Ca2+ efflux from cardiomyocytes, we examined the influence 
of Ca2+ or Na+ deprivation from the medium on the efflux. It 
has been reported that the decline in [Ca2+]¡ may be primarily 
due to both the mechanism of Na+/Ca2+ exchange at the 
plasma membrane and Ca2+ uptake into the sarcoplasmic 
reticulum [10]. As shown in Fig. 2, rat ANP(l-28)-induced 
Ca2+ efflux from cardiomyocytes was dependent on the pres-
ence of extracellular Na+, but not on Ca2+. The removal of 
Na+ from the incubation medium essentially inhibits Na+ / 
Ca2+ exchange to extrude intracellular Ca2+ outside the cells, 
which in turn allows Na+ influx. These results suggest that 
ANP stimulates Ca2+ efflux from cardiomyocytes through the 
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mechanism of Na+/Ca2+ exchange. This suggestion is also 
supported by the finding that rat ANP(l-28) caused a signifi-
cant 22Na+ influx into the cells. It has been reported that the 
Na+/Ca2+ exchanger is activated in the failing heart [19], and 
that cardiac ANP content and its secretion are increased in 
congestive heart failure [20,21]. Considering these findings, it 
is reasonable to speculate that ANP may activate the Na+ / 
Ca2+ exchanger concomitantly with the progress of heart fail-
ure. Irrespective of this, it is assumed that the acceleration of 
Na+/Ca2+ exchange through the plasma membrane plays a 
key role in ANP-induced Ca2+ efflux from cardiomyocytes. 
As the existence of natriuretic peptide receptors (NPR) in 
cardiomyocytes has been reported [22], ANP may affect these 
receptors in the cells. These NPRs can be classified into three 
major subgroups, i.e., NPR-A, NPR-B, and NPR-C [22]. It is 
indicated that NPR-A, which is stimulated by ANP and BNP, 
and NPR-B, which is recognized by CNP, both couple to 
guanylate cyclase to produce cGMP in cardiomyocytes [23]. 
However, recently identified NPR-C, which is lacking guany-
late cyclase, is thought to participate in peptide clearance [24]. 
We then examined the effects of rat BNP-45 and CNP-22 on 
Ca2+ efflux from the cardiomyocytes. Although rat CNP-22 is 
identical to human CNP-22, rat BNP-45 was employed for 
our experiments because it is the major circulating form of 
rat BNP which shows hypotensive and natriuretic properties 
[25]. As shown in Table 1, Ca2+ efflux from the cells was 
stimulated by CNP-22 to almost the same extent as by rat 
ANP(l-28), but not by rat BNP-45. Although the reason 
why BNP failed to induce Ca2+ efflux is unclear at present, 
it can be explained in part by the lower affinity of BNP to 
NPR-A in rat tissues [26]. As an alternative explanation, less 
potency of BNP than of ANP in activating guanylate cyclase 
may be involved [23]. These possibilities were confirmed in the 
present study by the finding that cGMP production was en-
hanced by rat ANP(l-28) and by CNP-22, but not by rat 
BNP-45 (Table 2). Nevertheless, it may be assumed that the 
stimulatory effects of ANP and CNP on Ca2+ efflux from 
cardiomyocytes is mediated by NPR-A and NPR-B, respec-
tively. Since it has been reported that stimulation of these two 
receptors causes an increase in cGMP within the cells [23], it is 
conceivable that the stimulatory effects of these peptides on 
Ca2+ efflux from the cardiomyocytes occurs through the acti-
vation of guanylate cyclase. We have previously reported that 
dibutyryl cGMP and sodium nitroprusside, which are known 
as potent activators of guanylate cyclase, induce Ca2+ efflux 
from bovine adrenal chromaffin cells through the Na+/Ca2+ 
exchange mechanism [27]. From these findings it may be rea-
sonable to speculate that ANP-induced Ca2+ efflux from adult 
rat cardiomyocytes may be mediated by the mechanism of 
Na+ /Ca2 + exchange, and this in turn may accelerate Ca2+ 
efflux from the cardiomyocytes, due to the increase in 
cGMP that results from activation of NPRs coupled to gua-
nylate cyclase. However, the exact mechanism which causes 
Ca2+ efflux from cardiomyocytes is still unclear. We are fur-
ther investigating the intracellular mechanism involved in 
ANP-induced Ca2+ efflux from freshly isolated adult rat car-
diomyocytes. 
In conclusion, ANP stimulates Ca2+ efflux from adult rat 
cardiomyocytes, probably through NPR. The underlying 
mechanism which causes Ca2+ efflux from the cells is still 
not entirely understood; however, it can be explained at least 
in part by a Na+ /Ca2 + exchange mechanism mediated by an 
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